Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,564 |
|
|||||
| News | - | ||||||
| Day High | 33.0899 | Low High |
|||||
| Day Low | 32.56 | ||||||
| Etf Name | Etf Symbol | Market | Stock Type |
|---|---|---|---|
| ALPS Medical Breakthroughs ETF | SBIO | AMEX | Exchange Traded Fund |
| Price Change | Price Change % | Etf Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0145 | 0.04% | 32.9401 | 13:48:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 32.61 | 32.56 | 33.0899 | 32.9256 |
| Trades | Etfs Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27 | 2,564 | 32.88 | 84,316 | - | 23.21 - 38.80 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:48:18 | 34 | 33.055 | USD |
ALPS Medical Breakthroughs ETF Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 117M | 3.18M | - | 163k | -17.09M | -5.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News ALPS Medical Breakthroug...
Real-Time news about ALPS Medical Breakthroughs ETF (American Stock Exchange): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
SBIO Historical
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 32.09 | 33.17 | 31.00 | 31.93 | 12,159 | 0.8501 | 2.65% |
| 1 Month | 34.64 | 34.8148 | 31.00 | 32.82 | 11,777 | -1.70 | -4.91% |
| 3 Months | 33.71 | 38.80 | 31.00 | 35.06 | 13,589 | -0.7699 | -2.28% |
| 6 Months | 23.71 | 38.80 | 23.21 | 32.31 | 12,043 | 9.23 | 38.93% |
| 1 Year | 29.97 | 38.80 | 23.21 | 31.16 | 10,352 | 2.97 | 9.91% |
| 3 Years | 49.80 | 50.895 | 23.21 | 34.76 | 17,121 | -16.86 | -33.86% |
| 5 Years | 34.69 | 64.04 | 23.21 | 38.49 | 26,597 | -1.75 | -5.04% |
| The Fund seeks investment results that correspond before fees and expenses generally to the performance of its underlying index the Poliwogg Medical Breakthroughs ndexSM ticker symbol PMBI the Underlying Index. The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. |
